Baidu contributed to a round pushing the medication supply platform developer's overall funding near to the $500m mark.
Yaoshibang, the China-based operator of a supply chain platform for the pharmaceutical industry, raised $270m in funding from investors including internet group Baidu yesterday, DealStreetAsia reported.
Zhejiang Pearl River Investment Management, Green Pine Capital Partners and Guangzhou City Construction Investment’s SF Fund also participated in the round, along with unnamed insurance firms and sovereign wealth funds. It was facilitated by China Renaissance.
Operated by holding company Guangzhou Sudao Information Technology, Yaoshibang operates an online platform which allows chemists, health clinics…
